We are live on ! Find out more
JBIO

Jade Biosciences
JBIO

49 hedge funds and large institutions have $396M invested in Jade Biosciences in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 25 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

9% more funds holding

Funds holding: 45 → 49 (+4)

0.02% less ownership

Funds ownership: 3.04% → 3.02% (-0.02%)

17% less capital invested

Capital invested by funds: $475M → $396M (-$79.9M)

72% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 25

Holders
49
Holders Change
+4
Holders Change %
+8.89%
% of All Funds
0.83%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
8
Increased
7
Reduced
25
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VA
VR Adviser
New York
+$6M
2
LCM
Lynx1 Capital Management
Puerto Rico
+$1.7M
3
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$577K
4
PL
Parkwood LLC
Ohio
+$442K
5
N
Nuveen
North Carolina
+$334K

Top Sellers

1
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
-$6.35M
2
CAM
Cormorant Asset Management
Massachusetts
-$1.36M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.16M
4
BlackRock
BlackRock
New York
-$567K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$514K
Name Holding Trade Value Shares
Change 		Change in
Stake
Allspring Global Investments
51
Allspring Global Investments
North Carolina
– -$17K -27 Closed
1 2
3